Terms: = Sarcomas AND CARS, P49589, 833, ENSG00000110619
63 results:
1. [Analysis of ultrasound images features and diagnostic model establishment of alveolar soft part sarcoma and intramuscular capillary-type hemangiomas].
Hu WJ; Wang ZH; Wu G; Guo XN; Dong CX; Kang H; Liu QY; Yuan JJ; Yang X
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(8):608-613. PubMed ID: 38389238
[No Abstract] [Full Text] [Related]
2. A novel nomogram and recursive partitioning analysis for predicting cancer-specific survival of patients with subcutaneous leiomyosarcoma.
Ji Q; Hu H; Li S; Tang J
Sci Rep; 2024 Feb; 14(1):2861. PubMed ID: 38311615
[TBL] [Abstract] [Full Text] [Related]
3. Ct-based intratumoral and peritumoral radiomics for predicting prognosis in osteosarcoma: A multicenter study.
Su Q; Wang N; Wang B; Wang Y; Dai Z; Zhao X; Li X; Li Q; Yang G; Nie P
Eur J Radiol; 2024 Mar; 172():111350. PubMed ID: 38309216
[TBL] [Abstract] [Full Text] [Related]
4. Postoperative Relapse Prediction in Patients With Ewing Sarcoma Using Computed Tomography-Based Radiomics Models Covering Tumor Per Se and Peritumoral Signatures.
Liu Y; Yin P; Cui J; Sun C; Chen L; Hong N
J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):766-773. PubMed ID: 37707407
[TBL] [Abstract] [Full Text] [Related]
5. Development of clinical and magnetic resonance imaging-based radiomics nomograms for the differentiation of nodular fasciitis from soft tissue sarcoma.
Wang C; Zhang Z; Dou Y; Liu Y; Chen B; Liu Q; Wang S
Acta Radiol; 2023 Sep; 64(9):2578-2589. PubMed ID: 37593946
[TBL] [Abstract] [Full Text] [Related]
6. Studies related to osteosarcoma and metabolism from 1990 to 2022: A visual analysis and bibliometric study.
Shao Z; Bi S
Front Endocrinol (Lausanne); 2023; 14():1144747. PubMed ID: 36950694
[TBL] [Abstract] [Full Text] [Related]
7. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
Sullivan PM; Kumar R; Li W; Hoglund V; Wang L; Zhang Y; Shi M; Beak D; Cheuk A; Jensen MC; Khan J; Dimitrov DS; Orentas RJ
Mol Cancer Ther; 2022 Oct; 21(10):1608-1621. PubMed ID: 35877472
[TBL] [Abstract] [Full Text] [Related]
8. B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
Zhang S; Black RG; Kohli K; Hayes BJ; Miller C; Koehne A; Schroeder BA; Abrams K; Schulte BC; Alexiev BA; Heimberger AB; Zhang A; Jing W; Ng JCK; Shinglot H; Seguin B; Salter AI; Riddell SR; Jensen MC; Gottschalk S; Moore PF; Torok-Storb B; Pollack SM
Mol Cancer Ther; 2022 Jun; 21(6):999-1009. PubMed ID: 35405743
[TBL] [Abstract] [Full Text] [Related]
9. Cost-minimization analysis of biweekly dosing of cetuximab and FOLFIRI compared with panitumumab and FOLFOX for first-line treatment of patients with KRAS wild-type metastatic colorectal cancer in the United States.
Gathirua-Mwangi WG; Sethi H; Afable MG; Bhattacharyya D; Khan T
J Med Econ; 2021; 24(1):1164-1172. PubMed ID: 34529522
[TBL] [Abstract] [Full Text] [Related]
10. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1.
Fierle JK; Brioschi M; de Tiani M; Wetterwald L; Atsaves V; Abram-Saliba J; Petrova TV; Coukos G; Dunn SM
Cell Rep Med; 2021 Aug; 2(8):100362. PubMed ID: 34467246
[TBL] [Abstract] [Full Text] [Related]
11. Case 290: Intravascular Cystic Synovial Sarcoma.
Yan H; Zhou C; Yan F; Wen X; Luo Y
Radiology; 2021 Jun; 299(3):730-735. PubMed ID: 34029167
[TBL] [Abstract] [Full Text] [Related]
12. Radiomics Nomograms Based on Non-enhanced MRI and Clinical Risk Factors for the Differentiation of Chondrosarcoma from Enchondroma.
Pan J; Zhang K; Le H; Jiang Y; Li W; Geng Y; Li S; Hong G
J Magn Reson Imaging; 2021 Oct; 54(4):1314-1323. PubMed ID: 33949727
[TBL] [Abstract] [Full Text] [Related]
13. ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma.
Merker M; Wagner J; Kreyenberg H; Heim C; Moser LM; Wels WS; Bonig H; Ivics Z; Ullrich E; Klingebiel T; Bader P; Rettinger E
Front Immunol; 2020; 11():581468. PubMed ID: 33193388
[TBL] [Abstract] [Full Text] [Related]
14. Metastatic Low-Grade Sarcoma with cars-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.
Jiao XD; Liu K; Xu M; Yu G; Liu D; Huang T; Qin BD; Liu M; Wu Y; Ling Y; Liu J; He X; Wang L; Li Y; Chen S; Zang YS
Oncologist; 2021 Apr; 26(4):e524-e529. PubMed ID: 32997436
[TBL] [Abstract] [Full Text] [Related]
15. Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.
Ogawa K; Koh Y; Kaneda H; Izumi M; Matsumoto Y; Sawa K; Fukui M; Taniguchi Y; Yoshimoto N; Tamiya A; Ando M; Kubo A; Isa SI; Saka H; Matsumura A; Kawaguchi T
BMJ Open; 2020 Sep; 10(9):e035615. PubMed ID: 32907893
[TBL] [Abstract] [Full Text] [Related]
16. Extraskeletal myxoid chondrosarcoma: A high incidence of metastatic disease to lymph nodes.
Claxton MR; Reynolds G; Wenger DE; Rose PS; Houdek MT
J Surg Oncol; 2020 Dec; 122(8):1662-1667. PubMed ID: 32808356
[TBL] [Abstract] [Full Text] [Related]
17. VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma.
Englisch A; Altvater B; Kailayangiri S; Hartmann W; Rossig C
Pediatr Blood Cancer; 2020 Oct; 67(10):e28313. PubMed ID: 32729251
[TBL] [Abstract] [Full Text] [Related]
18. Intraarticular Inflammatory Myofibroblastic Tumor of the Left Knee With ALK-cars Fusion Detected With Archer Fusionplex Sarcoma NGS Panel: Case Report and Literature Review.
Pineda-Díaz J; Solar I; Hershkovitz D; Drukman I; Sher O
Int J Surg Pathol; 2021 Apr; 29(2):216-222. PubMed ID: 32631118
[TBL] [Abstract] [Full Text] [Related]
19. Wound complications are a predictor of worse oncologic outcome in extremity soft tissue sarcomas.
Dadras M; Koepp P; Wallner C; Wagner JM; Sogorski A; Lehnhardt M; Harati K; Behr B
Surg Oncol; 2020 Jun; 33():126-134. PubMed ID: 32561077
[TBL] [Abstract] [Full Text] [Related]
20. A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma.
Marec-Berard P; Dalban C; Gaspar N; Brugieres L; Gentet JC; Lervat C; Corradini N; Castex MP; Schmitt C; Pacquement H; Tabone MD; Brahmi M; Metzger S; Blay JY; Pérol D;
Eur J Cancer; 2020 Jan; 125():58-68. PubMed ID: 31838406
[TBL] [Abstract] [Full Text] [Related]
[Next]
